Keros Therapeutics, Inc. (KROS) Net income 2019–2025
Keros Therapeutics, Inc. (KROS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$87.0MFY2025 · since FY2019: -$12.3M → $87.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $87.0M | +146.4% |
| FY2024 | -$187.4M | -22.5% |
| FY2023 | -$153.0M | -46.2% |
| FY2022 | -$104.7M | -78.2% |
| FY2021 | -$58.7M | -29.5% |
| FY2020 | -$45.4M | -267.7% |
| FY2019 | -$12.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice